| |
|
|
|
OncoSec Medical Incorporated  
|
|
4.5 0.19 (0.04%) |
09-18 16:00 |
|
Open: |
4.26 |
Pre close: |
4.31 |
Target:
|
5.43
|
|
High: |
4.5 |
Low: |
4.09 |
Resistance:
|
4.65
5.43
|
|
Volume: |
391,012 |
Market Cap: |
104M |
Support:
|
3.67
3.06
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.92
 |
MACD |
MACD(12,26):
|
0.09 |
|
MA(20): |
3.64 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
2.87 |
Stochastic Oscillator |
%K(14,3):
|
87.58 |
|
MA(250): |
2.26 |
%D(3): |
70.90 |
|
Average Volume(K) |
3-Month: |
40325
|
52-Week |
High:
|
5.40 |
|
10-Days: |
28017 |
Low: |
1.04 |
|
RSI |
RSI(14):
|
69.02 |
Change(%): |
115.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.083 |
Return on Equity (ttm) |
-190.2 |
Shares Out. (M) |
23.05 |
|
EPS Est. Current Year |
-1.020 |
Return on Assets (ttm) |
-76.2 |
Shares Float (M) |
9.47 |
|
EPS Est. Next Year |
-0.820 |
PEG Ratio |
0.00 |
% Held by Insiders |
60.40 |
|
EPS Est. Next Quarter |
-0.260 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
7.90 |
|
Forward EPS |
-4.290 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
219 |
|
Book Value (p.s.) |
0.950 |
EBITDA (p.s.) |
-1.740 |
P/E |
-1.46 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.74 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-31.88 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-15.71 |
P/CF |
-3.25 |
|
|
|
|
|
|
